The advertisement promotes Entyvio as a superior treatment option compared to Humira for patients with moderately to severely active ulcerative colitis, highlighting its efficacy in clinical remission.
Creative Information
| CID: | 43a010f4-e00e-4163-9cfa-5ef056b55138 |
| CRID: | 82_6854-857430 |
| Domain: | entyviohcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $0.04 |
| Timestamp: | 11/18/2025, 9:20:31 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/18/2025, 11:24:48 PM | 5.34s | |
| adomain_analysis | success | 11/19/2025, 2:44:55 AM | 3.68s | |
| adomain_capture | success | 11/19/2025, 2:44:51 AM | 0.10s | |
| ad_render | success | 11/18/2025, 11:24:43 PM | 24.44s | |
| brand_mapping | success | 11/18/2025, 9:20:32 PM | 0.14s | |
Analysis Results
Ad Format: banner
Brands: Entyvio
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1590.78 KB | ||||||||||||||||||||||
| Render Time: | 8.96 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1590.90 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
